Cargando…
Comparative Transcriptomic Analysis Reveals the Immunosuppressive Targets of Mesalazine in Dextran Sulfate Sodium-Induced Ulcerative Colitis
Ulcerative colitis (UC) is a complex inflammatory bowel disorder that can induce colonic and rectal dysfunction. Mesalazine, a first-line medicine, is routinely prescribed for UC treatment. However, the pharmacological targets of mesalazine against UC are not detailed in current publications. In the...
Autores principales: | Li, Rong, Cheng, Lin, Wang, Qi, Zhou, Liming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386351/ https://www.ncbi.nlm.nih.gov/pubmed/34456974 http://dx.doi.org/10.3389/fgene.2021.698983 |
Ejemplares similares
-
Integrated Analysis Reveals the Targets and Mechanisms in Immunosuppressive Effect of Mesalazine on Ulcerative Colitis
por: Li, Rong, et al.
Publicado: (2022) -
Bortezomib protects against dextran sulfate sodium-induced ulcerative colitis in mice
por: Hu, Li-Hong, et al.
Publicado: (2017) -
Therapeutic Mechanism and Effect of Camptothecin on Dextran Sodium Sulfate-Induced Ulcerative Colitis in Mice
por: Wang, Yizhuo, et al.
Publicado: (2021) -
Therapeutic effect of imiquimod on dextran sulfate sodium-induced ulcerative colitis in mice
por: Chen, Lu, et al.
Publicado: (2017) -
Glycyrrhetic Acid Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Vivo
por: Jeon, Yong-Deok, et al.
Publicado: (2016)